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Simplifying Progress

Advanced control strategies for the continuous production of
monoclonal antibodies (poster #12)
Thomas Kruse, Markus Kampmann, Jonas Austerjost, Johannes Lemke and David Pollard | Corporate Research
Integrated Continuous Biomanufacturing V | October 2022

Introduction

Continuous processing platform

USP

Capture

•Perfusion process
•Cell retention
device

•SMB affinity
chromatography

▪

Offering:
▪
▪
▪
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Increased productivity/resin
utilization
Reduced buffer consumption
Reduced manufacturing facility
footprint

Virus
inactivation
•Acidification and
neutralization

Sterile filtration
•Precipitate
removal

…
•…
•…

Experimental approach

Dynamic loading
Continuous SMB processes still rely on predefined recipes
Required assumptions (drawbacks):
▪
▪
▪

C1

Constant and known product concentration in the feed
All columns have the same binding capacity
Binding capacity remains constant throughout the entire process

Dynamic loading offers several advantages
▪
▪
▪

Enables control of column switching based on product breakthrough detection
Ability to compensate for variable chromatography product loading situations (USP)
Minimize product loss due to changing titers or column capacity

Product breakthrough detection
▪

Commonly obtained by spectroscopy methods like UV absorbance measurement, but UV is
quite unspecific and has a very high background signal due to media components of the USP

C4

→ Need for alternative PAT method
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Experimental approach

Biolayer interferometry (BLI)
▪

Bio-Layer Interferometry (BLI) is a label-free
technology for measuring biomolecular interactions

▪

Analyzes the interference pattern of white light
reflected from two surfaces: a layer of immobilized
protein on the biosensor tip, and an internal reference
layer

▪

Binding between a ligand immobilized on the
biosensor tip surface and an analyte in solution
produces an increase in optical thickness at the
biosensor tip

→ Wavelength shift
→ Proportional to the concentration of the analyte

Until now BLI systems, like the Octet platform,
consist exclusively of off-line analytic systems
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Experimental approach

Continuous BLI measurement
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Schematic representation of the flow paths within the
continuous BLI prototype
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Cycle step

Binding rate

Exemplary binding signal and binding rate for 3 cycles of
continuous BLI measurement of perfusion permeate.
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Experimental approach

Setup continuous processing platform
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